CooperVision lancerer MyDay Energys® : næste generations optiske design udviklet til enestående komfort (1,2)

september 21, 2026

Nye premium endagskontaktlinser(3) kombinerer innovativt optisk design med Aquaform® Technology(4-6) for at give en behagelig brugeroplevelse(3) i dagens krævende livsstil.(7)

Göteborg 19. september 2026 – CooperVision®, en global markedsleder inden for kontaktlinser,*8 har i dag annonceret lanceringen af MyDay Energys® i Danmark og introducerer dermed sin mest komfortable endagskontaktlinse nogensinde.1,2 Produktet er tilgængeligt fra 19. september. Denne førsteklasses endagskontaktlinse3 er udviklet til at imødekomme de behov, som nutidens synskrævende livsstil stiller7 og kombinerer innovativt optisk design med materialevidenskab4  for at give enestående komfort hele dagen.3

 

Da vi bruger stadig mere tid foran digitale skærme i løbet af dagen,9 er komforten blevet en af de vigtigste faktorer, der påvirker tilfredsheden med kontaktlinser.†10 Selvom komforten ved kontaktlinser ofte udelukkende forbindes med kontaktlinsematerialet, tyder forskning på, at visuelle krav også kan spille en vigtig rolle for den samlede brugeroplevelse med kontaktlinser.11

 

MyDay Energys® er udviklet med fokus på denne bredere tilgang til komfort. Kontaktlinsen kombinerer CooperVisions ComfortBoost™ Technology med Aquaform® Technology,4–6 som sammen sikrer komfortable og afslappede øjne hele dagen.‡12

 

ComfortBoost™ Technology hjælper øjnene med at bevare fokus med mindre anstrengelse ved hverdagens synsopgaver, hvilket fremmer synskomforten hele dagen.§◊1,13 Aquaform® Technology binder vand i kontaktlinsens materiale, hvilket giver naturlig fugtighed og bidrager til en utrolig komfort hele dagen.3

 

Kliniske undersøgelser viser, at brugerne har en stærk præference for denne kontaktlinse.‡1,12 Brugerne vurderede komforten ved dagens afslutning som højere med MyDay Energys® sammenlignet med MyDay®.Dobbelt så mange brugere foretrak MyDay Energys®  fordi øjnene føltes mindre tørre ved dagens afslutning.1 Brugerne rapporterede også, at øjnene føltes behagelige og afslappede igennem hele dagen, selvom de ofte kiggede på digitale enheder.‡12

 

Ved at imødekomme både de visuelle behov og materialekomfort §1,4tilbyder MyDay Energys® en mere helhedsorienteret løsning, når det gælder kontaktlinsekomfort for nutidens kontaktlinsebrugere.

 

»Komfort er stadig en af de vigtigste faktorer for tilfredshed med kontaktlinser, og forventningerne stiger fortsat i takt med, at brugerne tilbringer mere tid foran skærme på arbejde, derhjemme og når de er på farten«, siger Martin Lingvall, Professional Affairs Manager i Norden. »MyDay Energys® bygger videre på de gennemprøvede egenskaber i MyDay® -familien og introducerer en ny tilgang til komfort, der tager højde for både kontaktlinsemateriale og synskrav. Vi ser frem til at tilbyde denne seneste innovation til optikerbranchen i Danmark.«

 

MyDay Energys® supplerer CooperVisions etablerede MyDay®-familie, der omfatter sfæriske, toriske, multifokale og myopibehandlende alternativer, hvilket hjælper optikerne med at imødekomme behovene hos et bredt spektrum af kontaktlinsebrugere med en omfattende portefølje af endagskontaktlinser.14

 

MyDay Energys® er nu tilgængelige i Danmark.

 

For mere information, besøg https://coopervision.dk/kontaktlinser/myday-energys

 

###

 

Mediekontakt

Lisa Valinder Olsson

CooperVision

+46 705520200

lvalinderolsson@coopervision.se

About CooperVision

CooperVision, a division of CooperCompanies (Nasdaq: COO), is a global leader in contact lens innovation, dedicated to advancing vision at every stage of life. The company offers one of the industry’s most comprehensive portfolios of soft and specialty contact lenses—including daily disposable, two-week and monthly options—with high performance materials and optics across spherical, toric, and multifocal designs. With a strong heritage of addressing complex vision challenges such as childhood myopia, astigmatism, presbyopia, and irregular corneas, CooperVision combines purposeful research and development, state of the art manufacturing, and deep practitioner partnerships to deliver clinically advanced solutions. Decades of experience and insight continue to shape the eye care profession and create meaningful advantages for both practitioners and wearers. For more information, visit www.coopervision.com

 

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.

Footnotes

*Combination of 2022 market research based on global volume data and internal estimates.

19.1% of points where respondents were asked to divide 100 points over a number of aspects.

23% strongly agreed, 31% agreed, 21% slightly agreed.

§Compared to MyDay® sphere.

◊Based on a statistically significant difference of the mean change in Accommodative Microfluctuations and when compared to a lens without DigitalBoost™/Digital Zone Optics® after reading on an iPhone 5 for 20 minutes held at a distance of 25 cm. Study conducted with Biofinity Energys® and sphere.

 

 

References

1. CVI data on file, 2018. Prospective, multi-center (5 US sites), open label, bilateral wear, one-week dispensing study with MyDay® and MyDay Energys®. N=77 habitual soft CL wearers.

2. CVI data on file, 2024 & 2026.

3. CVI data on file, 2026.

4. CVI data on file, 2024.

5.  CVI data on file, 2016; bilateral, double masked, multi-centre, cross over study with Biofinity and Biofinity Energys. N=44 habitual soft contact lens wearers.

6. Montani G et al. Effects of different contact lens design on accommodative function and eyestrain symptoms of young adult subjects after VDT use. BCLA 2021 conference presentation.

7. CVI data on file, 2023. US in market assessment survey conducted by 23 ECPs:  n=207 habitual contact lens patients refit into MyDay Energys® contact lenses after one week of daily wear. ECP's Top 2 Box: 100%.

8. CVI data on file, 2023.

9. Kumar, N. Average Screen Time Statistics 2026 (By Age & Country) Average Screen Time Statistics 2026 [By Age & Country] Accessed 15th April 2026.

10. Coopervision data on file, 2024, Consumer segmentation online survey, Decision Analyst, August 2024. Contact lens wearers, n= 3725 (n=1200 US, n=499 UK, n=503 Germany, n=500 Japan, n=350 South Korea, n= 248 Poland, n=425 Italy).

11. Rueff EM. Visual discomfort and contact lens wear: A review. Contact Lens and Anterior Eye. 2023;46(4):101872.

12. CVI data on file, 2018. Prospective, multi-center (5 US sites), open label, bilateral wear, one week dispensing study with MyDay Energys®. N=77 habitual soft CL wearers.

13. Kajita M et al. Changes in accommodative micro-fluctuations after wearing contact lenses of different optical designs. CLAE 2020; 43(5): 493-496.

14. CVI data on file 2022; Rx coverage database n=203,946 eyes; 14 to 41 years for MyDay® sphere and MyDay® toric and MyDay Energys®; 42 to 70 years for MyDay® multifocal.

SA20110_DA